
Apararenone
CAS No. 945966-46-1
Apararenone ( MT-3995 | MT3995 )
产品货号. M16779 CAS No. 945966-46-1
Apararenone (MT-3995) 是一种新型强效、选择性非甾体盐皮质激素受体拮抗剂,用于治疗糖尿病肾病和非酒精性脂肪性肝炎。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥502 | 有现货 |
![]() ![]() |
10MG | ¥680 | 有现货 |
![]() ![]() |
25MG | ¥1061 | 有现货 |
![]() ![]() |
50MG | ¥1531 | 有现货 |
![]() ![]() |
100MG | ¥2236 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Apararenone
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Apararenone (MT-3995) 是一种新型强效、选择性非甾体盐皮质激素受体拮抗剂,用于治疗糖尿病肾病和非酒精性脂肪性肝炎。
-
产品描述Apararenone (MT-3995) is a novel potent, selective non-steroidal mineralocorticoid receptor antagonist for the treatment of diabetic nephropathies and non-alcoholic steatohepatitis.Steatohepatitis Phase 2 Clinical.
-
体外实验——
-
体内实验Recently, a phase II clinical trial has been initiated among patients with non-alcoholic steatohepatitis (NASH) in Japan.
-
同义词MT-3995 | MT3995
-
通路Nuclear Receptor/Transcription Factor
-
靶点MLR
-
受体MLR
-
研究领域Other Indications
-
适应症Steatohepatitis
化学信息
-
CAS Number945966-46-1
-
分子量364.391
-
分子式C17H17FN2O4S
-
纯度>98% (HPLC)
-
溶解度DMSO : ≥ 125 mg/mL 343.04 mM
-
SMILESCS(=O)(NC1=CC=C2N(C3=CC=C(F)C=C3)C(C(C)(C)OC2=C1)=O)=O
-
化学全称N-(4-(4-fluorophenyl)-2,2-dimethyl-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-7-yl)methanesulfonamide
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Kolkhof P, et al. Curr Opin Nephrol Hypertens. 2015 Sep;24(5):417-24.
2. Kolkhof P, et al. J Endocrinol. 2017 Jul;234(1):T125-T140.